La chaîne d'options affiche les données clés des options sur actions de  à différents prix d'exercice et dates d'expiration. Les traders utilisent ces informations pour analyser les transactions potentielles et évaluer le sentiment du marché pour ..

 (OTC:MSTEV) Stock, Chaîne d'Options

Arcus Biosciences (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RCUS#NYSE">RCUS</a>) reported quarterly losses of $(1.14) per share which missed the analyst consensus estimate of $(1.02) by 11.76 percent. This is a 2180 percent decrease over losses of $(0.05) per share from the same period last year. The company reported quarterly sales of $28.00 million which missed the analyst consensus estimate of $36.54 million by 23.37 percent. This is a 80.69 percent decrease over sales of $145.00 million the same period last year.

Earnings

Earnings Misses

News

RCUS

Arcus Biosciences Q1 EPS $(1.14) Misses $(1.02) Estimate, Sales $28.00M Miss $36.54M Estimate

Chord Energy (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CHRD#NASDAQ">CHRD</a>) reported quarterly earnings of $4.04 per share which beat the analyst consensus estimate of $3.52 by 14.77 percent. This is a 20.78 percent decrease over earnings of $5.10 per share from the same period last year. The company reported quarterly sales of $1.10 billion which missed the analyst consensus estimate of $1.22 billion by 9.86 percent. This is a 47.40 percent increase over sales of $748.30 million the same period last year.

Earnings Beats

CHRD

Chord Energy Q1 Adj. EPS $4.04 Beats $3.52 Estimate, Sales $1.10B Miss $1.22B Estimate

Aviat Networks (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AVNW#NASDAQ">AVNW</a>) affirms FY2025 sales outlook from $430.00 million-$470.00 million to $430.00 million-$470.00 million vs $435.96 million estimate.

Guidance

AVNW

Aviat Networks Affirms FY2025 Sales Guidance of $430.00M-$470.00M vs $435.96M Est

Chemours (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CC#NYSE">CC</a>) reported quarterly earnings of $0.13 per share which missed the analyst consensus estimate of $0.21 by 38.1 percent. This is a 59.38 percent decrease over earnings of $0.32 per share from the same period last year. The company reported quarterly sales of $1.37 billion which beat the analyst consensus estimate of $1.35 billion by 1.18 percent. This is a 1.33 percent increase over sales of $1.35 billion the same period last year.

Chemours Q1 Adj. EPS $0.13 Misses $0.21 Estimate, Sales $1.37B Beat $1.35B Estimate

Unitil To Acquire Aquarion Water Company of Massachusetts For $100M

Electric vehicle company Rivian Automotive (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RIVN#NASDAQ">RIVN</a>) reported first-quarter financial results <a href="https://www.benzinga.com/earnings">after market close Tuesday.</a>
Here are the key highlights.
What Happened: Rivian reported first-quarter revenue of $1.24 billion, up 3% year-over-year. The revenue total beat a Street consensus estimate of $1.00 billion according to data<a href="https://www.benzinga.com/pro/register?utm_adType=bzprocontent&amp;utm_campaign=14daytrial&amp;utm_ad=0506"> from Benzinga Pro.</a>
The company reported a loss of 48 cents per share, beating a Street consensus estimate of a loss of 76 cents per share.
Rivian highlighted that it hit $206 million in positive gross profit for the first quarter. This marked the company's second consecutive quarter of gross profit.
Rivian previously reported first-quarter production and deliveries of 14,611 vehicles and 8,640 vehicles respectively.
"This quarter we hit our second consecutive gross profit and our highest gross profit to date at $206 million. We have continued to make significant progress on R2, including vehicle validation builds underway and our Normal, Illinois manufacturing facility expansion on track," Rivian CEO RJ Scaringe said.
Rivian also unlocked $1 billion through an investment from Volkswagen Group (OTC:<a class="ticker" href="https://www.benzinga.com/stock/VWAGY#OTC">VWAGY</a>), which is expected to be funded on June 30, 2025.
Rivian had over 7,000 "electric joyrides" at SXSW festival in Austin in March and a total of 36,000 demo drives in the first quarter of 2025. The company said this was a quarterly record for demos.
The first quarter also saw the announced partnership with HelloFresh for 70 Rivian Commercial Vans, which marks the company's first major fleet customer outside of original partner and investor Amazon.com Inc.
Read Also: <a href="https://www.benzinga.com/analyst-ratings/analyst-color/25/05/45205696/rivian-q1-earnings-preview-all-eyes-on-r2-launch-analyst-says-no-catalysts-in-2025">Rivian Q1 Earnings Preview: All Eyes On R2 Launch, Analyst Says &#8216;No Catalysts In 2025&#8217;</a>
What's Next: The company highlighted its progress made on the R2, which is scheduled to begin production in the first half of 2026.
Rivian said the company manufactures 100% of its vehicles in the U.S. and gets the majority of its materials from the U.S., but it is not immune to the impact of tariffs and the macroeconomic environment.
The company shared new guidance for vehicle deliveries in 2025, ranging from 40,000 to 46,000 vehicles, down from prior guidance of 46,000 to 51,000 vehicles.
"The company's guidance represents management's current view on evolving trade regulation, policies, tariffs, and the overall impact these items may have on consumer sentiment and demand," the company said.
Rivian maintained guidance for adjusted EBITDA in a range of a loss of $1.7 billion to a loss of $1.9 billion.
The company expects to hit "modest" positive gross profits for the full fiscal year.
RIVN Price Action: Rivian stock is down 0.2% to $13.47 in after-hours trading Tuesday versus a 52-week trading range of $9.25 to $18.86.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/trading-ideas/technicals/25/05/45234062/rivian-charges-up-lucid-stuck-in-neutral-tesla-rivals-q1-earnings-face-off">Rivian Vs. Lucid: One Of These Tesla Rivals Is Stuck In Neutral Ahead Of Q1 Earnings</a></li>
</ul>
Photo: Shutterstock

Movers

Trading Ideas

RIVN

VWAGY

Rivian Q1 Earnings: Double Beat, Record Gross Profit, Delivery Estimates Lowered On Tariff Concerns

Amentum Holdings (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AMTM#NYSE">AMTM</a>) affirms FY2025 Adj EPS guidance from $2.00-$2.20 to $2.00-$2.20 vs $2.11 analyst estimate. Narrows FY2025 sales outlook from $13.80 billion-$14.20 billion to $13.85 billion-$14.15 billion vs $14.06 billion estimate.

AMTM

Amentum Holdings Affirms FY2025 Adj EPS Guidance of $2.00-$2.20 vs $2.11 Est; Narrows FY2025 Sales Guidance from $13.80B-$14.20B to $13.85B-$14.15B vs $14.06B Est

Aviat Networks (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AVNW#NASDAQ">AVNW</a>) reported quarterly earnings of $0.88 per share which beat the analyst consensus estimate of $0.28 by 214.29 percent. This is a 12.82 percent increase over earnings of $0.78 per share from the same period last year. The company reported quarterly sales of $112.64 million which beat the analyst consensus estimate of $104.83 million by 7.45 percent. This is a 1.64 percent increase over sales of $110.82 million the same period last year.

Aviat Networks Q3 Adj. EPS $0.88 Beats $0.28 Estimate, Sales $112.64M Beat $104.83M Estimate

Astera Labs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ALAB#NASDAQ">ALAB</a>) is looking for Q2 Adj EPS of $0.32-$0.33 vs $0.30 analyst estimate. sees sales of $170.000 million-$175.000 million vs $160.29 million analyst estimate.

ALAB

Astera Labs Sees Q2 Adj EPS $0.32-$0.33 vs $0.30 Est; Sees Sales $170.000M-$175.000M vs $160.29M Est

Safehold (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SAFE#NYSE">SAFE</a>) reported quarterly earnings of $0.44 per share which beat the analyst consensus estimate of $0.42 by 4.76 percent. This is a 2.33 percent increase over earnings of $0.43 per share from the same period last year. The company reported quarterly sales of $97.70 million which beat the analyst consensus estimate of $96.06 million by 1.71 percent. This is a 4.81 percent increase over sales of $93.21 million the same period last year.

SAFE

Safehold Q1 Adj. EPS $0.44 Beats $0.42 Estimate, Sales $97.70M Beat $96.06M Estimate

Amentum Holdings Q2 Adj. EPS $0.53 Beats $0.47 Estimate, Sales $3.49B Beat $3.43B Estimate

Rigel Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RIGL#NASDAQ">RIGL</a>) reported quarterly earnings of $0.63 per share which beat the analyst consensus estimate of $0.09 by 600 percent. This is a 226 percent increase over losses of $(0.50) per share from the same period last year. The company reported quarterly sales of $53.30 million which beat the analyst consensus estimate of $43.87 million by 21.50 percent. This is a 80.47 percent increase over sales of $29.53 million the same period last year.

RIGL

Rigel Pharmaceuticals Q1 EPS $0.63 Beats $0.09 Estimate, Sales $53.30M Beat $43.87M Estimate

iRobot (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IRBT#NASDAQ">IRBT</a>) reported quarterly losses of $(1.95) per share which missed the analyst consensus estimate of $(1.27) by 53.54 percent. This is a 27.45 percent decrease over losses of $(1.53) per share from the same period last year. The company reported quarterly sales of $101.57 million which missed the analyst consensus estimate of $125.00 million by 18.74 percent. This is a 32.29 percent decrease over sales of $150.01 million the same period last year.

IRBT

iRobot Q1 Adj. EPS $(1.95) Misses $(1.27) Estimate, Sales $101.57M Miss $125.00M Estimate

Opendoor Technologies (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OPEN#NASDAQ">OPEN</a>) reported quarterly losses of $(0.09) per share which beat the analyst consensus estimate of $(0.10) by 10 percent. This is a 25 percent increase over losses of $(0.12) per share from the same period last year. The company reported quarterly sales of $1.15 billion which beat the analyst consensus estimate of $1.06 billion by 8.88 percent. This is a 2.37 percent decrease over sales of $1.18 billion the same period last year.

OPEN

Opendoor Technologies Q1 Adj. EPS $(0.09) Beats $(0.10) Estimate, Sales $1.15B Beat $1.06B Estimate

Option Care Health (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OPCH#NASDAQ">OPCH</a>) has outperformed the market over the past 5 years by 7.99% on an annualized basis producing an average annual return of 21.81%. Currently, Option Care Health has a market capitalization of $5.35 billion. 
Buying $100 In OPCH: If an investor had bought $100 of OPCH stock 5 years ago, it would be worth $245.06 today based on a price of $32.66 for OPCH at the time of writing.
<h3>Option Care Health's Performance Over Last 5 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1746563422_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

OPCH

If You Invested $100 In This Stock 5 Years Ago, You Would Have This Much Today

Ford Motor Co (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/F#NYSE">F</a>) reported its first-quarter earnings on Monday. The following are comments from different analysts about the company&#8217;s performance.
BofA analyst John Murphy reiterated a Buy rating on the shares with a price forecast of $14.00.
Ford reported a first-quarter 2025 adjusted EPS of $0.14, surpassing both their own estimate of ($0.05) and the Bloomberg consensus of ($0.04). 
Adjusted EBIT was $1.0 billion, exceeding the forecast of $0.03 billion. Strong performance from Ford Blue and Model E drove the beat, while Ford Credit exceeded expectations, and Ford Pro fell short. 
EBIT was impacted by ~$200 million in tariff costs. Following the results and tariff impacts, the 2025 estimates have been lowered, while 2026 and 2027 estimates remain mostly unchanged, said the analyst.
Ford has suspended its guidance despite reporting strong business performance. It cites supply chain disruptions, tariff uncertainties, potential retaliatory actions, and policy changes regarding emissions regulations as the reasons.
Also Read: <a href="https://www.benzinga.com/25/05/45231071/whats-going-on-with-ev-maker-rivian-stock-today">What&#8217;s Going On With EV Maker Rivian Stock On Tuesday?</a>
The company estimates a gross tariff cost of $2.5 billion for FY25, with a net EBIT impact of approximately $1.5 billion, expecting to offset 40% of the tariff costs. 
Despite these challenges, Ford&#8217;s strong truck market position and large U.S. manufacturing footprint leave the company well-positioned to gain market share, opined the analyst.
Goldman Sachs analyst Mark Delaney reiterated a Neutral rating on the shares and raised the price forecast from $9.00 to $10.00.
Ford reported first-quarter revenue of $40.7 billion and adjusted EPS of $0.14, surpassing expectations. However, the company suspended its 2025 guidance due to uncertainties surrounding tariffs, policy and industry dynamics.
Ford estimates a $2.5 billion gross tariff exposure, with a net EBIT impact of $1.5 billion. Despite this, the company remains positive about its strong U.S. market position and long-term cost reduction potential. 
However, the analyst said challenges from international competition and a premium valuation lead to a maintained Neutral rating on the stock.
Price Action: Ford shares traded higher by 2.56% at $10.43 at last check on Tuesday.
Read Next: <a href="https://www.benzinga.com/25/05/45194848/footwear-giant-skechers-to-go-private-in-more-than-9b-deal-with-3g-capital-stock-surges">Footwear Giant Skechers To Go Private At 30% Premium In PE Deal</a>
Photo: Shutterstock

Price Target

Reiteration

Analyst Ratings

General

Ford Outperforms In Q1, Faces Tariff Challenges Ahead, Say Analysts

Porch Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PRCH#NASDAQ">PRCH</a>) raises FY2025 sales outlook from $390.00 million-$410.00 million to $400.00 million-$420.00 million vs $399.07 million estimate.

PRCH

Porch Group Raises FY2025 Sales Guidance from $390.00M-$410.00M to $400.00M-$420.00M vs $399.07M Est

<h3>GAINERS:</h3>
<ul>
<li><a href="https://www.benzinga.com/quote/BBRRF">Blueberries Medical</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/BBRRF#OTC">BBRRF</a>) shares closed up 21.95% at $0.01</li>
<li><a href="https://www.benzinga.com/quote/FFNTF">4Front Ventures</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/FFNTF#OTC">FFNTF</a>) shares closed up 18.67% at $0.00</li>
<li><a href="https://www.benzinga.com/quote/TGIFF">1933 Industries</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/TGIFF#OTC">TGIFF</a>) shares closed up 13.40% at $0.01</li>
<li><a href="https://www.benzinga.com/quote/OGI">Organigram Global</a> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OGI#NASDAQ">OGI</a>) shares closed up 6.26% at $1.10</li>
<li><a href="https://www.benzinga.com/quote/CURR">Currenc Group</a> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CURR#NASDAQ">CURR</a>) shares closed up 4.89% at $1.27</li>
<li><a href="https://www.benzinga.com/quote/LBUY">Leafbuyer Techs</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/LBUY#OTC">LBUY</a>) shares closed up 4.88% at $0.02</li>
<li><a href="https://www.benzinga.com/quote/NWVCF">EnWave</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/NWVCF#OTC">NWVCF</a>) shares closed up 3.89% at $0.22</li>
<li><a href="https://www.benzinga.com/quote/CWBHF">Charlottes Web Holdings</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/CWBHF#OTC">CWBHF</a>) shares closed up 3.41% at $0.09</li>
<li><a href="https://www.benzinga.com/quote/CBWTF">Auxly Cannabis Group</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/CBWTF#OTC">CBWTF</a>) shares closed up 3.33% at $0.06</li>
</ul>
<h3>LOSERS:</h3>
<ul>
<li><a href="https://www.benzinga.com/quote/YCBD">cbdMD</a> (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/YCBD#AMEX">YCBD</a>) shares closed down 28.86% at $0.13</li>
<li><a href="https://www.benzinga.com/quote/RMHB">Rocky Mountain High</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/RMHB#OTC">RMHB</a>) shares closed down 18.03% at $0.00</li>
<li><a href="https://www.benzinga.com/quote/CRBP">Corbus Pharmaceuticals</a> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CRBP#NASDAQ">CRBP</a>) shares closed down 11.59% at $6.25</li>
<li><a href="https://www.benzinga.com/quote/CNBX">CNBX Pharmaceuticals</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/CNBX#OTC">CNBX</a>) shares closed down 11.11% at $0.00</li>
<li><a href="https://www.benzinga.com/quote/SOLCF">SOL Global Investments</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/SOLCF#OTC">SOLCF</a>) shares closed down 9.01% at $0.08</li>
<li><a href="https://www.benzinga.com/quote/OILFF">Nextleaf Solutions</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/OILFF#OTC">OILFF</a>) shares closed down 7.91% at $0.04</li>
<li><a href="https://www.benzinga.com/quote/CNTMF">FLUENT</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/CNTMF#OTC">CNTMF</a>) shares closed down 6.70% at $0.05</li>
<li><a href="https://www.benzinga.com/quote/CURLF">Curaleaf Holdings</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/CURLF#OTC">CURLF</a>) shares closed down 6.33% at $0.87</li>
<li><a href="https://www.benzinga.com/quote/GTBIF">Green Thumb Indus</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/GTBIF#OTC">GTBIF</a>) shares closed down 5.76% at $6.05</li>
<li><a href="https://www.benzinga.com/quote/XXII">22nd Century Group</a> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/XXII#NASDAQ">XXII</a>) shares closed down 4.91% at $1.19</li>
<li><a href="https://www.benzinga.com/quote/GNLN">Greenlane Hldgs</a> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GNLN#NASDAQ">GNLN</a>) shares closed down 4.69% at $0.01</li>
<li><a href="https://www.benzinga.com/quote/ZDPY">Zoned Properties</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/ZDPY#OTC">ZDPY</a>) shares closed down 4.55% at $0.42</li>
<li><a href="https://www.benzinga.com/quote/CLSH">CLS Holdings USA</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/CLSH#OTC">CLSH</a>) shares closed down 4.29% at $0.03</li>
<li><a href="https://www.benzinga.com/quote/TCNNF">Trulieve Cannabis</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/TCNNF#OTC">TCNNF</a>) shares closed down 4.28% at $4.47</li>
<li><a href="https://www.benzinga.com/quote/TLRY">Tilray Brands</a> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TLRY#NASDAQ">TLRY</a>) shares closed down 3.94% at $0.42</li>
<li><a href="https://www.benzinga.com/quote/CRLBF">Cresco Labs</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/CRLBF#OTC">CRLBF</a>) shares closed down 3.86% at $0.86</li>
<li><a href="https://www.benzinga.com/quote/CXXIF">C21 Investments</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/CXXIF#OTC">CXXIF</a>) shares closed down 3.66% at $0.16</li>
<li><a href="https://www.benzinga.com/quote/GRWG">GrowGeneration</a> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GRWG#NASDAQ">GRWG</a>) shares closed down 3.45% at $1.12</li>
<li><a href="https://www.benzinga.com/quote/IIPR">Innovative Ind Props</a> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IIPR#NYSE">IIPR</a>) shares closed down 3.16% at $53.00</li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Cannabis

Markets

BBRRF

CANNABIS WHEATON INCOME by Cannabis Wheaton Income Corp.

CBWTF

CLSH

CNBX

CNTMF

CRBP

CRLBF

CURALEAF HLDGS INC by Curaleaf Hldgs Inc.

CURLF

CURE PHARMA HLDG CORP by CURE Pharmaceutical Holding Corp.

CURR

CWBHF

CXXIF

FFNTF

GNLN

GRWG

GTBIF

IIPR

LEAFBUYER TECHNOLOGIES by Leafbuyer Technologies, Inc.

LBUY

NWVCF

OILFF

RMHB

SOLCF

TCNNF

TGIFF

TLRY

XXII

YCBD

ZDPY

Cannabis Stock Gainers And Losers From May 6, 2025

Porch Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PRCH#NASDAQ">PRCH</a>) reported quarterly earnings of $0.08 per share which beat the analyst consensus estimate of $(0.12) by 166.67 percent. This is a 138.1 percent increase over losses of $(0.21) per share from the same period last year. The company reported quarterly sales of $104.75 million which beat the analyst consensus estimate of $79.44 million by 31.86 percent. This is a 9.27 percent decrease over sales of $115.44 million the same period last year.

Porch Group Q1 EPS $0.08 Beats $(0.12) Estimate, Sales $104.75M Beat $79.44M Estimate

Jamf Holding (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/JAMF#NASDAQ">JAMF</a>) raises FY2025 sales outlook from $675.50 million-$680.50 million to $691.00 million-$695.00 million vs $676.04 million estimate.

Comments

(MSTEV) Options

No option chain data available. Please try again later

Notizie

PARTENAIRE / CONTRIBUTEUR

BENZINGA MONDIAL